VIVABIOTECH：InterimReport2023.pdf

1、Interim Report 20231CONTENTS2Corporate Information4Management Discussion and Analysis16Supplementary Information40Independent Review Report42Interim Condensed Consolidated Statement of Profit or Loss43Interim Condensed Consolidated Statement of Comprehensive Income44Interim Condensed Consolidated St

2、atement of Financial Position46Interim Condensed Consolidated Statement of Changes in Equity48Interim Condensed Consolidated Statement of Cash Flows50Notes to Interim Condensed Consolidated Financial Information92Definitions2Viva Biotech Holdings Corporate Information AUTHORIZED REPRESENTATIVESMr.WU

3、 YingMs.CHAU Hing Ling(a fellow member of the Chartered Governance Institute(formerly known as the Institute of Chartered Secretaries and Administrators)and The Hong Kong Chartered Governance Institute(formerly known as the Hong Kong Institute of Chartered Secretaries)AUDITORErnst&YoungCertified Pub

4、lic AccountantsRegistered Public Interest Entity Auditor27/F,One Taikoo Place979 Kings RoadQuarry BayHong KongLEGAL ADVISERSOMelveny&Myers(as to Hong Kong law)Maples and Calder(Hong Kong)LLP (as to Cayman Islands laws)PRINCIPAL BANKSAgricultural Bank of China Shanghai BranchThe Hongkong and Shanghai

5、 Banking Corporation LimitedBank of China(Hong Kong)LimitedJP Morgan Chase Bank,N.A.Citibank N.A.,Hong Kong BranchREGISTERED OFFICEPO Box 309Ugland HouseGrand Cayman,KY1-1104Cayman IslandsBOARD OF DIRECTORSExecutive DirectorsMr.MAO Chen Cheney(Chairman of the Board)Mr.WU YingMr.REN DelinNon-executiv

6、e DirectorMr.WU YutingIndependent Non-executive DirectorsMr.FU LeiMs.LI XiangrongMr.WANG HaiguangAUDIT COMMITTEEMs.LI Xiangrong(Chairman)Mr.WANG HaiguangMr.FU LeiREMUNERATION COMMITTEEMs.LI Xiangrong(Chairman)Mr.WANG HaiguangMr.FU LeiNOMINATION COMMITTEEMr.MAO Chen Cheney(Chairman)Mr.WANG HaiguangMr